Clinical Trial Update: Brain Natriuretic Peptide (BNP) to Preserve Renal Function in Hospitalized Patients With Heart Failure [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Brain Natriuretic Peptide (BNP) to preserve renal function in hospitalized patients with congestive heart failure has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiomyopathy
• Chronic Kidney Disease
• Heart Failure

Drugs mentioned

• Nesiritide (recombinant human B-type natriuretic peptide (rhBNP))

Snippet

Sponsor: Mayo Clinic | Conditions: Kidney Diseases, Congestive Heart Failure | Phase 3 | Status: COMPLETED